Latest Revenue Guidance News

Page 12 of 14
DXN Limited reported a modest 2% revenue increase to $2.5 million in Q3 FY25, launched its Data Centre as a Service division with a $3.6 million initial contract, and progressed a key acquisition valued at $10 million, positioning itself for growth despite some project delays.
Sophie Babbage
Sophie Babbage
30 Apr 2025
MedAdvisor Solutions reported a challenging third quarter with steep revenue declines, driven by delayed program launches and US sales underperformance, but is executing a strategic overhaul and cost-cutting measures to position for a rebound and 15% revenue growth in FY26.
Ada Torres
Ada Torres
30 Apr 2025
Genesis Resources has completed its acquisition of full ownership of the Plavica JV in North Macedonia and is progressing environmental studies and exploration planning for multiple Australian tenements ahead of 2025 drilling campaigns.
Maxwell Dee
Maxwell Dee
30 Apr 2025
Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.
Ada Torres
Ada Torres
30 Apr 2025
Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.
Ada Torres
Ada Torres
30 Apr 2025
Fluence Corporation reported a robust Q1 2025 with revenue surging 64.5% year-over-year, driven by the Ivory Coast Addendum project, while EBITDA turned positive for the first time in over a year. The company maintains its full-year guidance despite tariff uncertainties.
Victor Sage
Victor Sage
30 Apr 2025
Fluence Corporation Limited reported a robust 64.5% revenue increase in Q1 2025, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams, while maintaining its full-year guidance.
Victor Sage
Victor Sage
30 Apr 2025
Nova Eye Medical reported a 27% rise in Q3FY25 sales excluding China, driven by record US performance and a sharp reduction in glaucoma segment losses. The company confirmed FY25 revenue guidance and unveiled plans to expand its iTrack™ technology into ocular drug delivery.
Ada Torres
Ada Torres
29 Apr 2025
Aroa Biosurgery reports a second consecutive quarter of positive operating cash flow and record sales for its Myriad product line, while maintaining full-year FY25 revenue and EBITDA guidance.
Ada Torres
Ada Torres
29 Apr 2025
Atturra Limited reports a robust first half of FY25 with revenue growth nearing 28%, driven by recent acquisitions and expanding service offerings, while updating full-year guidance amid cautious government sector risks.
Sophie Babbage
Sophie Babbage
18 Feb 2025
SEEK Limited’s FY2025 half-year results reveal a revenue dip and profit contraction, yet the company delivers a robust free cash flow surge and raises its interim dividend, underscoring resilience amid evolving market conditions.
Sophie Babbage
Sophie Babbage
18 Feb 2025
Infomedia Ltd delivered a robust first half FY25 with a 63% jump in net profit after tax and a 7% rise in underlying cash EBITDA, despite challenges in its SimplePart e-commerce segment. The company’s strategic acquisition of AI specialist Intellegam signals a bold push into data-driven automotive solutions.
Sophie Babbage
Sophie Babbage
18 Feb 2025